Saturday, October 3, 2026

Back to today

From X

Nike, Part Two: The Deep Dive

Nike’s second Latticework program examines the company and the global athletic footwear and apparel industry for professional investors.

Nike, Part One: The Story

Nike grew from a $1,000 shoe-distribution venture in 1964 into the largest sports brand, using athlete endorsements, product innovation and…

KRYS · short

Krystal Biotech INC

Krystal Biotech is a profitable commercial-stage biotech with an $8.7 billion enterprise value and one FDA-approved topical gene therapy,…

“The tip of the iceberg.”

Stevanato's 8% organic Q2 growth and 21% adjusted EBITDA growth came with a modest FY 2026 guidance lift after the Balda divestiture.

A Venezuela Lottery Ticket for 41 Cents

Lionheart Holdings’ 41-cent CUBWW warrants hinge on a SPAC merger valuing KEO Energy’s Venezuelan PetroUrdaneta stake at $1 billion, versus…

Microsoft: Control Your Destiny

Microsoft’s cloud business grew from a $12 billion FY16 run rate to about $237 billion by FY26, while AI-era CapEx may exceed $200 billion…

Publications we follow

Every publication on this site, hand-picked.

128 publications

Newsletters 106

X accounts we follow

Every account on this site, hand-picked.

84 accounts

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.